(Total Views: 326)
Posted On: 08/06/2020 12:05:55 PM
Post# of 24
$RFL News Article - Rafael Pharmaceuticals Achieves Target Enrollment of 500 Patients in Pivotal Phase 3 Trial (AVENGER 500) of CPI-613 ? (devimistat) for Patients with Metastatic Pancreatic Cancer https://marketwirenews.com/news-releases/rafa...24772.html
(0)
(0)
My Twitter: WhyteStocks
